(1 - 10 from 17
)
Google News: Canaccord Genuity Cuts Price Target on Dendreon (DNDN) After Q4, But Keeps Buy ...
[StreetInsider.com (subscription)] - Analyst George Farmer comments, " sales appear to be driven more by sign-up of new accounts rather than "same-store sales," indicating that urologist 'cost density' [doctors unwilling to pay for a treatment before getting reimbursed by insurance
Oxford Tories who failed to pay £1200 bill
www.telegraph.co.uk
[Telegraph.co.uk] - The cash and cheques for the dinner were handed by attendees to George Farmer, the club's social secretary and then a student at St Peter's College. He is the son of Michael Farmer, a City financier and Conservative Party donor and is now an analyst at
Google News: Canaccord Genuity Reiterates a 'Buy' on Synta Pharma (SNTA); Ganetespid Update
[StreetInsider.com (subscription)] - Analyst, George Farmer, said, "We reiterate our rating on SNTA shares on our view of ganetespib promise for treatment of non-small cell lung cancer (NSCLC) and potentially other solid tumors." "The company intends to follow a g-pib regulatory path
Google News: Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Uncertain ...
[StreetInsider.com (subscription)] - Analyst, George Farmer, said, "We see a number of factors negatively affecting Adcetris sales performance this year, including a higher gross-net sales adjustment (as guided), a near complete exhaustion of a one-time patient pool treated during the
sorted by relevance / date